$8.59
-0.84-8.91%
Dern. MÀJ: Oct 22, 4:05 PM
Atara Biotherapeutics (ATRA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.25 | $0.32 | $-0.07 | $-0.73 |
| Actual | $-0.32 | $-0.29 | $-0.25 | $-0.32 |
| Surprise | -28.0% | -190.6% | -257.1% | +56.2% |
| Revenue | ||||
| Estimate | $366670 | $2.2M | $1.6M | $2.2M |
| Actual | $630000 | $516000 | $1.6M | $3.5M |
| Surprise | +71.8% | -76.3% | -2.35% | +59.9% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.22 | $-0.19 |
| Revenue | ||
| Consensus | $533330 | $900000 |
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-0.32 | $-0.25 | -28.0 % |
| Q1 | May 12, 2026 | $-0.29 | $0.32 | -190.6 % |
| Q4 | Mar 16, 2026 | $-0.25 | $-0.07 | -257.1 % |
| Q3 | Nov 12, 2025 | $-0.32 | $-0.73 | 56.2 % |
| Trimestre Fiscal | Date de Déclaration | Revenu Réel | Revenu Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $630.00K | $366.67K | 71.8 % |
| Q1 | May 12, 2026 | $516.00K | $2.17M | -76.3 % |
| Q4 | Mar 16, 2026 | $1.60M | $1.63M | -2.35 % |
| Q3 | Nov 12, 2025 | $3.45M | $2.16M | 59.9 % |